Search | SIU School of Medicine

Showing: 1314 Results

Profiles

Elizabeth Nietert, MD

Assistant Professor of Clinical Internal Medicine, Division of Dermatology

Internal Medicine

Profiles

Elizabeth Steere, LPC

Profiles

Elizabeth Tatum, MD

Assistant Professor of Clinical Internal Medicine

Internal Medicine

Profiles

Elle Quinn, DO

Family Medicine Residency Program | Quincy

Profiles

Elliot Johns, MD

Orthopedic Surgery

Trial

Simmons Cancer Institute

EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients Who Have Previously Received 2 to 5 Years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer With an Increased Risk

Active recruiting

The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cancer that is estrogen receptor positive (ER+) and human epidermal receptor 2 negative (HER2-).

Profiles

Emilie Lohman Irwin, MD

Emergency Medicine

Profiles

Emily Hillman, MD

Urology

Profiles

Emily Kermicle, PA-C

Profiles

Emily Konopka, MD

Assistant Professor of Clinical Internal Medicine, Division of Dermatology

Internal Medicine

Search Results

Elizabeth Nietert, MD

Elizabeth Steere, LPC

Elizabeth Tatum, MD

Elle Quinn, DO

Elliot Johns, MD

EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients Who Have Previously Received 2 to 5 Years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer With an Increased Risk

Emilie Lohman Irwin, MD

Emily Hillman, MD

Emily Kermicle, PA-C

Emily Konopka, MD